These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 28373340)

  • 1. States With Prescription Drug Monitoring Mandates Saw A Reduction In Opioids Prescribed To Medicaid Enrollees.
    Wen H; Schackman BR; Aden B; Bao Y
    Health Aff (Millwood); 2017 Apr; 36(4):733-741. PubMed ID: 28373340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
    MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between prescription drug monitoring programs use mandates and prescription stimulants received by Medicaid enrollees.
    Gunadi C; Shi Y
    Drug Alcohol Rev; 2023 Nov; 42(7):1658-1666. PubMed ID: 37946605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mandatory use of prescription drug monitoring program and benzodiazepine prescribing among U.S. Medicaid enrollees.
    Liang D; Guo H; Shi Y
    Subst Abus; 2021; 42(3):294-301. PubMed ID: 31697195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescription Drug Monitoring Program Mandates: Impact On Opioid Prescribing And Related Hospital Use.
    Wen H; Hockenberry JM; Jeng PJ; Bao Y
    Health Aff (Millwood); 2019 Sep; 38(9):1550-1556. PubMed ID: 31479368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recreational marijuana legalization and prescription opioids received by Medicaid enrollees.
    Shi Y; Liang D; Bao Y; An R; Wallace MS; Grant I
    Drug Alcohol Depend; 2019 Jan; 194():13-19. PubMed ID: 30390550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of mandatory prescription drug monitoring program (PDMP) use laws on prescriber registration and use and on risky prescribing.
    Strickler GK; Zhang K; Halpin JF; Bohnert ASB; Baldwin GT; Kreiner PW
    Drug Alcohol Depend; 2019 Jun; 199():1-9. PubMed ID: 30954863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical cannabis legalization and opioid prescriptions: evidence on US Medicaid enrollees during 1993-2014.
    Liang D; Bao Y; Wallace M; Grant I; Shi Y
    Addiction; 2018 Nov; 113(11):2060-2070. PubMed ID: 29989239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prescription Drug Monitoring Programs Are Associated With Sustained Reductions In Opioid Prescribing By Physicians.
    Bao Y; Pan Y; Taylor A; Radakrishnan S; Luo F; Pincus HA; Schackman BR
    Health Aff (Millwood); 2016 Jun; 35(6):1045-51. PubMed ID: 27269021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of prescriber risk indicators obtained from prescription drug monitoring program data.
    Kreiner PW; Strickler GK; Undurraga EA; Torres ME; Nikitin RV; Rogers A
    Drug Alcohol Depend; 2017 Apr; 173 Suppl 1():S31-S38. PubMed ID: 28363317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incremental Effect of the Addition of Prescriber Restrictions on a State Medicaid's Pharmacy-Only Patient Review and Restriction Program.
    Keast SL; Pham T; Teel A; Nesser NJ
    J Manag Care Spec Pharm; 2017 Aug; 23(8):875-883. PubMed ID: 28737989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid prescribing patterns after dental visits among beneficiaries of Medicaid in Washington state in 2014 and 2015.
    Obadan-Udoh E; Lupulescu-Mann N; Charlesworth CJ; Muench U; Jura M; Kim H; Schwarz E; Mertz E; Sun BC
    J Am Dent Assoc; 2019 Apr; 150(4):259-268.e1. PubMed ID: 30922457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Buprenorphine-Waivered Physician Supply With Buprenorphine Treatment Use and Prescription Opioid Use in Medicaid Enrollees.
    Wen H; Hockenberry JM; Pollack HA
    JAMA Netw Open; 2018 Sep; 1(5):e182943. PubMed ID: 30646185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in use of opioids for chronic noncancer pain among individuals with mental health and substance use disorders: the TROUP study.
    Edlund MJ; Martin BC; Devries A; Fan MY; Braden JB; Sullivan MD
    Clin J Pain; 2010 Jan; 26(1):1-8. PubMed ID: 20026946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Opioid Prescribing Habits Based on Analysis of a State Prescription Drug Monitoring Program.
    Alexander JC; Silge J; Jones S; Joshi GP
    Pain Physician; 2019 Sep; 22(5):E425-E433. PubMed ID: 31561654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Responsible, Safe, and Effective Prescription of Opioids for Chronic Non-Cancer Pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines.
    Manchikanti L; Kaye AM; Knezevic NN; McAnally H; Slavin K; Trescot AM; Blank S; Pampati V; Abdi S; Grider JS; Kaye AD; Manchikanti KN; Cordner H; Gharibo CG; Harned ME; Albers SL; Atluri S; Aydin SM; Bakshi S; Barkin RL; Benyamin RM; Boswell MV; Buenaventura RM; Calodney AK; Cedeno DL; Datta S; Deer TR; Fellows B; Galan V; Grami V; Hansen H; Helm Ii S; Justiz R; Koyyalagunta D; Malla Y; Navani A; Nouri KH; Pasupuleti R; Sehgal N; Silverman SM; Simopoulos TT; Singh V; Solanki DR; Staats PS; Vallejo R; Wargo BW; Watanabe A; Hirsch JA
    Pain Physician; 2017 Feb; 20(2S):S3-S92. PubMed ID: 28226332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Medical and Adult-Use Marijuana Laws With Opioid Prescribing for Medicaid Enrollees.
    Wen H; Hockenberry JM
    JAMA Intern Med; 2018 May; 178(5):673-679. PubMed ID: 29610827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Most primary care physicians are aware of prescription drug monitoring programs, but many find the data difficult to access.
    Rutkow L; Turner L; Lucas E; Hwang C; Alexander GC
    Health Aff (Millwood); 2015 Mar; 34(3):484-92. PubMed ID: 25732500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variations in prescription drug monitoring program use by prescriber specialty.
    Sun BC; Lupulescu-Mann N; Charlesworth CJ; Kim H; Hartung DM; Deyo RA; John McConnell K
    J Subst Abuse Treat; 2018 Nov; 94():35-40. PubMed ID: 30243415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Payor-Mandated Review of Prescription Drug Monitoring Program on Opioid Prescriber Rates.
    Schumann SO; Zhang J; McCauley JL; Heidari K; Ball SJ
    South Med J; 2020 Sep; 113(9):415-417. PubMed ID: 32885255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.